Document is current

Any future updates will be listed below

Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group

Crossref DOI link: https://doi.org/10.1186/s13045-016-0364-0

Published Online: 2016-11-30

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark